The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Onset of secondary progressive phase and long-term evolution of multiple sclerosis
Open accessAbstract
OBJECTIVES: To assess factors affecting the rate of conversion to secondary progressive (SP) multiple sclerosis (MS) and its subsequent evolution. METHODS: Among 806 patients with relapsing remitting (RR) onset MS from the London Ontario database, we used Kaplan-Meier, Cox regression and multiple logistic regression analyses to investigate the effect of baseline clinical and demographic features on (1) the probability of, and the time to, SP disease, (2) the time to bedbound status (Disability Status Scale (DSS 8)) from onset of progression. RESULTS: The risk of entering the SP phase increased proportionally with disease duration (OR=1.07 for each additional year; p<0.001). Shorter latency to SP was associated with shorter times to severe disability. The same association was found even when patients were grouped by number of total relapses before progression. However, the evolution of the SP phase was not influenced by the duration of the RR phase. Male sex (HR=1.41; p<0.001), older age at onset (age ≤20 and 21-30 vs >30 HR=0.52 (p<0.001), 0.65 (p<0.001), respectively) and high early relapse frequency (1-2 attacks vs ≥3 HR=0.63 (p<0.001), 0.75 (p=0.04), respectively) predicted significantly higher risk of SP MS and shorter latency to progression. Times to DSS 8 from onset of progression were significantly shorter among those with high early relapse frequency (≥3 attacks), and among those presenting with cerebellar and brainstem symptoms. CONCLUSIONS: The onset of SP MS is the dominant determinant of long-term prognosis, and its prevention is the most important target measure for treatment. Baseline clinical features of early relapse frequency and age at onset can be used to select groups at higher risk of developing severe disability based on the probability of their disease becoming progressive within a defined time period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Self-citationDefining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Self-citationThe relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
The natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Self-citationConfavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Natural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 905
Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897
Scalfari, A., Neuhaus, A., Degenhardt, A., Rice, G. P., Muraro, P. A., Daumer, M., & Ebers, G. C. (2010) · Brain · doi:10.1093/brain/awq118 · Cited by 711
Self-citationEvidence for a two-stage disability progression in multiple sclerosis
Leray, E., Yaouanq, J., Le Page, E., Coustans, M., Laplaud, D., Oger, J., & Edan, G. (2010) · Brain · doi:10.1093/brain/awq076 · Cited by 596
Age at disability milestones in multiple sclerosis
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awh714 · Cited by 525
Gray matter atrophy is related to long‐term disability in multiple sclerosis
Fisniku, L. K., Chard, D. T., Jackson, J. S., Anderson, V. M., Altmann, D. R., Miszkiel, K. A., Thompson, A. J., & Miller, D. H. (2008) · Annals of Neurology · doi:10.1002/ana.21423 · Cited by 500
Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up
(2008) · Archives of Neurology · doi:10.1001/archneur.65.6.727 · Cited by 476
Immunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Kremenchutzky, M., Rice, G. P. A., Baskerville, J., Wingerchuk, D. M., & Ebers, G. C. (2006) · Brain · doi:10.1093/brain/awh721 · Cited by 447
Self-citationA New Scale for Evaluating Disability in Multiple Sclerosis
Kurtzke, J. F. (1955) · Neurology · doi:10.1212/wnl.5.8.580 · Cited by 297
Axonal loss in normal-appearing white matter in a patient with acute MS
Bjartmar, C., Kinkel, R. P., Kidd, G., Rudick, R. A., & Trapp, B. D. (2001) · Neurology · doi:10.1212/wnl.57.7.1248 · Cited by 281
Age and disability accumulation in multiple sclerosis
Scalfari, A., Neuhaus, A., Daumer, M., Ebers, G. C., & Muraro, P. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318230a17d · Cited by 279
Self-citationShirani, A., Zhao, Y., Karim, M. E., Evans, C., Kingwell, E., van der Kop, M. L., Oger, J., Gustafson, P., Petkau, J., & Tremlett, H. (2012) · JAMA · doi:10.1001/jama.2012.7625 · Cited by 263
The natural history of secondary progressive multiple sclerosis
Koch, M., Kingwell, E., Rieckmann, P., Tremlett, H., & Neurologists, U. M. C. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208173 · Cited by 241
Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up
Sergott, R. C. (2009) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(09)79112-9 · Cited by 232
The contribution of demyelination to axonal loss in multiple sclerosis
DeLuca, G. C. (2006) · Brain · doi:10.1093/brain/awl074 · Cited by 231
Impact of multiple sclerosis relapses on progression diminishes with time
Tremlett, H., Yousefi, M., Devonshire, V., Rieckmann, P., & Zhao, Y. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1e44f · Cited by 221
Eriksson, M., Andersen, O., & Runmarker, B. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms914oa · Cited by 221
Natural history of secondary-progressive multiple sclerosis
Tremlett, H., Zhao, Y., & Devonshire, V. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084264 · Cited by 217
The natural history of multiple sclerosis: a geographically based study
Kremenchutzky, M., Cottrell, D., Rice, G., Hader, W., Baskerville, J., Koopman, W., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.10.1941 · Cited by 186
Self-citationNatural history of multiple sclerosis in a population‐based cohort
Debouverie, M., Pittion‐Vouyovitch, S., Louis, S., Guillemin, F., & for the LORSEP Group (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02241.x · Cited by 163
Predicting secondary progression in relapsing–remitting multiple sclerosis: a Bayesian analysis
Bergamaschi, R., Berzuini, C., Romani, A., & Cosi, V. E. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00572-x · Cited by 147
Trojano, M., Avolio, C., Manzari, C., Calò, A., Robertis, F. D., Serio, G., & Livrea, P. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.3.300 · Cited by 147
Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis
Scalfari, A., Neuhaus, A., Däumer, M., DeLuca, G. C., Muraro, P. A., & Ebers, G. C. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.599 · Cited by 141
Self-citationVukusic, S., & Confavreux, C. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00426-4 · Cited by 126
MRI as an outcome in multiple sclerosis clinical trials
Däumer, M., Neuhaus, A. A., Morrissey, S., Hintzen, R. Q., & Ebers, G. C. (2008) · Neurology · doi:10.1212/01.wnl.0000336916.38629.43 · Cited by 126
Self-citationProgression in multiple sclerosis: Further evidence of an age dependent process
Koch, M. W., Mostert, J. P., Heersema, D. J., & Keyser, J. D. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.067 · Cited by 118
Surrogate endpoints for EDSS worsening in multiple sclerosis
Sormani, M. P., Bonzano, L., Roccatagliata, L., Mancardi, G., Uccelli, A., & Bruzzi, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ea15aa · Cited by 116
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis
Sormani, M. P., Li, D. K., Bruzzi, P., Stubinski, B., Cornelisse, P., Rocak, S., & Stefano, N. D. (2011) · Neurology · doi:10.1212/wnl.0b013e31823648b9 · Cited by 114
MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS
Sormani, M. P., Filippi, M., Stefano, N. D., Ebers, G., & Daumer, M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd6b8f · Cited by 92
Self-citationNeurologists, A. T. U., Tremlett, H. L., Zhao, Y., & Devonshire, V. A. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0039-7 · Cited by 84
McDonald, W. I., Miller, D. H., & Thompson, A. J. (1994) · Annals of Neurology · doi:10.1002/ana.410360106 · Cited by 74
Skoog, B., Runmarker, B., Winblad, S., EKHOLM, S. E., & Andersen, O. (2012) · Brain · doi:10.1093/brain/awr336 · Cited by 60
Age at onset determines the occurrence of the progressive phase of multiple sclerosis
Stankoff, B., Mrejen, S., Tourbah, A., Fontaine, B., Lyon‐Caen, O., Lubetzki, C., & Rosenheim, M. (2007) · Neurology · doi:10.1212/01.wnl.0000256732.36565.4a · Cited by 60
Daumer, M., Held, U., Ickstadt, K., Heinz, M., Schach, S., & Ebers, G. (2007) · Nature Precedings · doi:10.1038/npre.2007.433.1 · Cited by 31
Self-citationThere is no such thing as a mild MS relapse. The mild relapse is an Anglo-Saxon delusion - Yes
Edan, G. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512450090 · Cited by 2
Cited by
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30475-6 · Cited by 942
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
How patients with multiple sclerosis acquire disability
Lublin, F. D., Häring, D. A., Ganjgahi, H., Ocampo, A., Hatami, F., Čuklina, J., Aarden, P., Dahlke, F., Arnold, D. L., Wiendl, H., et al. (2022) · Brain · doi:10.1093/brain/awac016 · Cited by 549
Brain health: time matters in multiple sclerosis
Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., Sormani, M. P., Thalheim, C., Traboulsee, A., & Vollmer, T. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.07.003 · Cited by 458
Defining secondary progressive multiple sclerosis
Lorscheider, J., Buzzard, K., Jokubaitis, V., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Girard, M., Duquette, P., et al. (2016) · Brain · doi:10.1093/brain/aww173 · Cited by 415
Metadata
- Authors
- Scalfari, A., Neuhaus, A., Daumer, M., Muraro, P. A., & Ebers, G. C.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2013-03-13
- Volume
- 85
- Issue
- 1
- Pages
- 67-75
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2148455753
- Cited by
- 291
- References
- 46
- FWCI
- 13.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.